Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.
Messenger RNA (mRNA) and microRNA (miRNA)-based therapeutics have become attractive alternatives to DNA-based therapeutics due to recent advances in manufacture, scalability and cost. Also, RNA-based therapeutics are considered safe since there are no risk of inducing genomic changes as well as the...
Main Authors: | Leena Ylösmäki, Beatrice Polini, Sara Carpi, Beatriz Martins, Elena Smertina, Sara Feola, Manlio Fusciello, Karita Peltonen, Paola Nieri, Erkko Ylösmäki, Vincenzo Cerullo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0224072 |
Similar Items
-
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
by: Sara Feola, et al.
Published: (2021-07-01) -
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy
by: Karita Peltonen, et al.
Published: (2021-07-01) -
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
by: Firas Hamdan, et al.
Published: (2021-03-01) -
Artificially cloaked viral nanovaccine for cancer immunotherapy
by: Manlio Fusciello, et al.
Published: (2019-12-01) -
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
by: Erkko Ylösmäki, et al.
Published: (2021-03-01)